Philadelphia, October 17, 2022 – Xponance, Inc., a multi-strategy investment firm, announced today that Michael A.B. Orr has joined the firm as Managing Director & Chief Investment Officer of the firm’s Alternatives subsidiary, Xponance Alts Solutions, LLC (“XAlts”). He will lead the investment strategy for Xponance Diverse Opportunities Fund, LP (“XDO”) and play a significant role in the planning and execution of future XAlts endeavors. In this designed role, Mr. Orr will report to Marquette Chester, Senior Managing Director, Head of Alternatives. Most recently, Mr. Orr was SVP & Senior Client Investment Officer in the not-for-profit OCIO practice of Northern Trust Asset Management. Mr. Orr is a member of the XDO investment Committee, along with Mr. Chester, Tina Byles Williams, (Xponance’s Founder and CEO), and the leadership of Investcorp’s Strategic Capital Group.
XAlts seeks to partner with a defined group of diverse and/or women-owned alternative managers through general partnership (GP) staking and selective seeding agreements. The platform draws upon parent company Xponance’s 25-year history of investing with diverse, emerging, and women-owned business enterprises on public market platforms.
Mr. Chester stated, “We are pleased to expand the depth and breadth of our team with the CIO role for XAlts. A.B. will significantly enhance our ongoing initiative to provide direct growth and expansion capital as well as to meet the strategic objectives of our targeted diverse and women-led alternative managers.”
Mr. Orr added, “The successful performance of diverse managers has been verified. I am excited to work with the XAlts team to partner with differentiated alpha-producing firms, particularly in the largely underserved diverse alternative manager community.”
He brings to Xponance more than 25 years of experience across the financial services industry as an asset allocator, investment banker, and private equity professional. Notably, Mr. Orr previously was the Executive Director, Alternative Investments at Providence St. Joseph Health, the third largest not-for-profit healthcare system in the U.S. He had lead authority for all alternative investments for Providence inclusive of private equity/debt, venture capital, hedge funds, and real assets – and is credited with developing and building out the firm’s private equity program. As part of this position, he was also a member of the Limited Partner Advisory Committee for more than fifteen external private asset funds. In addition, he held several company leadership roles, serving as a member of both the Executive Investment Committee and Valuation Committee for Providence Ventures, the organization’s venture capital affiliate, and as a member of Providence’s Socially Responsible Investing Committee. Prior to Providence, he gained more than fifteen years of M&A advisory and financing experience via investment banking – including senior roles at J.P. Morgan, Bank of America, and HSBC.
Mr. Orr is presently a member of the Strategic Advisory Board of Investcorp Strategic Capital Group. He formerly served on the Board of Directors for J.P. Morgan FCS Corporation and on the Client Advisory Board for Voya Investment Management.
Mr. Orr earned a Bachelor of Science degree in Economics from The Wharton School, University of Pennsylvania and an MBA from the Simon Business School, University of Rochester via a full-tuition fellowship awarded by The Consortium for Graduate Study in Management.
Xponance is a multi-strategy investment firm (approximately $12.1B AUM as of 9/30/22). We offer global and non-U.S. equity investment strategies by harnessing the investment edge and focus of entrepreneurial or emerging managers in a tested strategic framework. Our specialized due diligence techniques and product seeding of capacity constrained strategies are designed to generate sustainable alpha for our clients. As a direct investment manager, Xponance focuses on creating systematic, risk-controlled, active, and passive equity strategies. Our active U.S. fixed income strategies span the maturity spectrum and provide income and downside protection through differentiated off-benchmark and off the run securities. Aapryl, a technology company and subsidiary of Xponance, provides a web-based manager performance analytics and portfolio risk management platform that empowers investors to improve portfolio performance.
Xponance’s primary goals are to be a trusted client solutions partner and force multiplier for positive change in the investment industry. Our name is derived from the word “exponent” and dually connotes our core objectives—to be a zealous champion for our clients; and to provide higher level engagement and a broader array of solutions to meet their investment needs. We are employee owned by women and diverse professionals and believe that diversity provides an important and differentiated path for generating alpha.
Website & Social Media Links:
xponance.com | LinkedIn | Twitter
Managing Director & Head of Distribution & Client Engagement
Tel: (215) 567-1100 ex. 1207